Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibumetin and Expectancy in Axial Spondyloarthritis
NCT02089529Completed
- Sponsor
- University Hospital of North Norway
- Start
- Jan 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ibuprofen in axial spondyloarthritis (axSpA), sponsored by University Hospital of North Norway. Primary endpoints: Pain Intensity at 12 weeks, Pain Unpleasantness at 12 weeks and 1 more. Started Jan 2014; status: completed.
02
Drugs
ibuprofen
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT02089529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089529.